 |
Network Immunology | A Vancouver Biotech Company – Monoclonal Antibodies for HIV and the Treatement and Prevention of Autoimmune Diseases – One of a range of biotechnology investment opportunities in Canada
Network Immunology is a biotech company based in Vancouver BC, Canada. The company focuses on HIV vaccine development, organ transplantation facilitation technologies, treatments and preventions for autoimmune diseases, and other biotechnologies emerging from a Network Theory of the immune system as pioneered by Dr. Niels Jerne and Dr. Geoffrey W. Hoffmann. Network Immunology owns Intellectual Property rights to three industry-changing technologies, the scope of which are very large. Its primary focus is a preventive HIV vaccine. The company now has multiple lines of supporting evidence for this HIV vaccine. The company's second technology is a treatment that makes organ transplants safe and easy, even in the absence of a genetically matching donor. The company has strong supporting evidence at this stage and is raising capital for further development of its technologies. The achievement of upcoming milestones will put Network Immunology in the forefront of the biotechnology industry and ultimately help to enhance and prolong the lives of people worldwide. This Canadian company is currently offering investment opportunities. If one is interested, please contact us for further information about the opportunity.
Hoffitran.com ~
Site Info
Whois
Trace Route
RBL Check
Similar Sites:
networkimmunology.com
- networkimmunologyinc.com
|
 |
Information Center for Emerging Infectious Diseases, Faculty of Medicine, Chulalongkorn University - Home
Emerging Infectious Diseases, โรคติดเชื้อ, โรคติดเชื้ออุบัติใหม่,rabies,rabies virus,โรคพิษสุนัขบ้า,โรคทางสมอง,โรคอุบัติใหม่,h1n1, หวัด 2009, ไข้หวัดใหญ่สายพันธุ์ใหม่ 2009, influenza flu 2009, infectious disease
Cueid.org ~
Site Info
Whois
Trace Route
RBL Check
Similar Sites:
soonak.com
|
|
|
|
Site Info
